Dr. Peter Burkhard has obtained his PhD from the University of Basel, Switzeralnd. He is a professor at the University of Connecticut, Storrs, USA, in the field of nanobiotechnology. He is also co-Founder and CEO of Alpha-O Peptides AG, Riehen, Switzerland, a company dedicated to the development of nanoparticle vaccines.